Journals / Medical Network Klinik Bilimler ve Doktor / 2000 / Cilt: 6 - Sayı: 5

Effects of ten days preoperative mebendazole treatment on cyst viability of liver hydatid disease

Karaciğer kist hidatiğinde preoperatif 10 gün süreli mebendazol tedavisinin kist canlılığına etkisi

Pages
595–598
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ten days preoperative mebendazole treatment has no effect on cyst viability of liver hydatid disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To investigate the effects often days preoperative mebendazole treatment MA TERIAL AND METOD: Fourty patients with hydatid disease divided into two groups.
📊
Key Findings & Data:Group one (20 patients) received mebendazole treatment ten days preoperatively in a dose of 50mg/kg.
💡
Conclusion & Impact:Ten days preoperative mebendazole treatment has no effect on cyst viability of liver hydatid disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Karaciğer · Mebendazol · Kistler

Abstract

AIM: To investigate the effects often days preoperative mebendazole treatment MA TERIAL AND METOD: Fourty patients with hydatid disease divided into two groups. Group one (20 patients) received mebendazole treatment ten days preoperatively in a dose of 50mg/kg. Other twenty patients formed control groups. World Health Organization's guidelines for microbiologic and histopathologic evaluation of echinococcus was used. RESULTS AND CONCLUSION: Number of viable cysts was 14 and 15 and number of death cysts was six and five in group one and two respectively . Ten days preoperative mebendazole treatment has no effect on cyst viability of liver hydatid disease.

Özet

AMAÇ: Karaciğer kist hidatiğinde preoperatif 10 gün süreli mebendazol tedavisinin kist canlılığına etkisini araştırmak. GEREÇ ve YÖNTEM: Çalışmaya 40 karaciğer kist hidatikli hasta alındı. 20 hastaya (Grup 1) preoperatif, 10 gün boyunca 50mg/kg dozunda mebendazol tedavisi verildi. 20 hastaya (Grup 2) ise tedavi verilmedi. Kist canlılığının değerlendirilmesinde Dünya Sağlık teşkilatının yayınladığı mikrobiyojik ve histopatolojik kriterler kullanıldı. BULGULAR ve SONUÇ: Grup 1 'deki 14 kist canlı, 6 kist ölü. Grup 2 'deki 15 kist canlı, 5 kist ölü olarak değerlendirildi. Karaciğer kist hidatiğinde preoperatif 10 gün süreli mebendazol tedavisinin kist canlılığına etkisi yoktur

🔖

Cite This Article

BOSTANCI, E. B., TERZİ, C., KALE, İ. T., HENGİRMEN, S., SULTAN, N. (2000). Effects of ten days preoperative mebendazole treatment on cyst viability of liver hydatid disease. Medical Network Klinik Bilimler ve Doktor, Cilt: 6 - Sayı: 5, 595–598. https://ajindex.com/articles/279222

References (16)

  1. Menteş A. Hydatid liver disease: a perspective in treatment. Dig Dis 1994
  2. 160 2. Kaynaroglu V, Gökçe Ö, Tanık A, Kadıoğlu Y. Karaciğer kist hidatiği cerrahi tedavisi. Ulus Cer Derg 1990
  3. 69 3. Özden A, Çifter Ç, Akkuş MA, Kargıcı H, Kaşara E. Karaciğer kist hidatiğinde cerrahi yöntemlerin morbidite açısından karşılaştırılması. Klin Deney Cerrah Derg 1993
  4. 243 4. Demirci S, Eraslan Ş, Anadol E, Bozatlı L. Comparison of the results of different surgical techniques in the management of hydatid cysts of the livr. World J Surg 1989
  5. 91 5. Motlanghion H, Saidi F. Postoperative recurrence of hydatid disease. Br J Surg 1978: 65: 237-242 6.Win H, New RRL,Craıg PS. Diagnosis and treatment of human hydatidosis. Br J Clin Pharmac 1993
  6. 574 7. Sayek İ, Çakmakçı M. The effect of prophylactic mebendazole in experimental peritoneal hydatidosis. Surg Gynecol Obstet 1986
  7. 353 8.,L, Chinnery JB, Hardcastle JD. Can albendazole reduce the risk of implantation of spilled protoscolicis? An animal study. Trans R Soc Trop MedHyg 1986
  8. 484 9. Ranconi P, Borzone A, Alquati P, Pittiruti M. Preoperative treatment of hydatid cysts with mebendazole. Int Surg 1982
  9. 406 10.Smego DR, Smego RA. Hydatid Cyst: Preoperative sterilization with mebendazole. South Med J 1986
  10. 901 11.Morris DL. Preoperative Albendazole therapy for hydatid cyst. Br J Surg 1987
  11. 806 12.Türkçapar AG, Ersöz S, Güngör Ç, Aydın Uraz K, Yerdel MA, Araş N Surgical treatment of hepatic hydatidosis combined with peroperative treatment with albendazole. Eur J Surg 1997
  12. 928 13.FAO/UNEP/WHO Guidelines for surveillance, prevention and control of echinococcosis / hydatidos. Eckert J. Gemmell MA. Soulsby E.J.L.(eds). Food and Agriculture Organization of the United Nations, Rome. 1982
  13. 140 14.Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazole carbamates in human echinococcosis. Bull World Health Org 1986
  14. 388 15.Davis A, Dixon H, Pawlowski ZS. Multicentre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2) Bull World Health Org 1989
  15. 508 16.Kılıçturgay S, Akbulut E, İrgil C, Özen Y, Bilgel H: Deneysel hidatidozisde profılaktik amaçlı mebendazol ve albendazol uygulanmasının kist gelişimi üzerindeki etkisi. Ulus Cer Derg 1996
  16. 29 17.Aktan AO, Yalın R. Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur Gastroen